SC 13G

Company

RIGEL PHARMACEUTICALS INC

Filed

February 1, 2001

Accession Number

0000950005-01-000047

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →